National and Kapodistrian University of Athens
Προσδιορισμός του παράγοντα ενεργοποίησης των αιμοπεταλίων (PAF) στο αίμα ασθενών με διαβητική αμφιβληστροειδοπάθεια
Abstract
dc:descriptionBackground: Diabetic retinopathy (DR) is the most severe ocular complication of diabetes mellitus, accounting for 93 million of diabetic patients worldwide. Platelet activating factor (PAF) is a low molecular weight phospholipid, being implicating in enhanced vascular permeability and neovascularization observed in DR and other ocular diseases. Objective: To assess the role of plasma PAF acetylhydrolase (PAF-AH) in pathogenesis and progression of DR.Research design and methods: Sixty eight diabetics and 23 age-frequency-matched non-diabetic patients underwent blood sampling and the plasma PAF-AH activity was calculated. The diabetic patients were further classified into two groups, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, based on indirect fundoscopy and Fluorescein angiography. Thirty seven patients with non-proliferative DR (NPDR) and 31 patients with proliferative DR (PDR) were finally included in the study. Results: The plasma PAF-AH activity was increased in diabetic patients compared to control group (control: 0.114µmol/min/ml, NPDR: 0.147µmol/min/ml and PDR: 0.206µmol/min/ml) and the differences in means were statistically significant among groups [One-Way ANOVA, p<0.0001, F= 10 (2,88)].Conclusions: The activity of PAF-AH in the plasma increases in parallel with DR severity.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pantazis, Panagiotis
- Πανταζής, Παναγιώτης
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39928